PBM:NASDAQPsyence Biomedical Ltd. Analysis
Data as of 2026-09-05 - not real-time
$4.54
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Psyence Biomedical Ltd. is neutral at $4.54, with no clear ordering between short and long averages. Over a rolling month the price has gained 53.9%. Relative strength is 67.4 — approaching overbought — and the MACD signal is bullish. The recent range runs from support at $3.22 up to resistance at $5.00.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 91.3%, a beta of 3.16 and a maximum drawdown of 98.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 91.3%, a beta of 3.16 and a maximum drawdown of 98.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
Psyence Biomedical Ltd PBM shares are trading lower in Wednesday’s premarket session.NEW YORK, Aug. 18, 2026 GLOBE NEWSWIRE -- Psyence BioMed Ltd. Nasdaq: PBM "Psyence BioMed" or the "Company" , a...Nasdaq17dPsyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine DevelopmentNEW YORK, Aug....
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 13.30
- MACD momentum is positive
- 30-day price change of +53.9%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 13.30
- 30-day volatility of 91.3%
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative return on equity of -58.6%
- Negative free cash flow
- 30-day volatility of 91.3%
Key Metrics & Analysis
Financial Health
ROE-58.62%
ROA-31.33%
P/B Ratio0.6
Op. Cash Flow$-8143007
Free Cash Flow$-4955898
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI67.4
Support$3.22
Resistance$5.00
MA 20$4.05
MA 50$3.47
MA 200$13.30
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta3.16
Volatility91.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.